Bio + Healthcare

Genesis Therapeutics is pioneering AI technologies to create medicines for patients with severe and unmet medical needs.

Delfi Diagnostics has developed a test that combines ultra-low-cost sequencing and machine learning to detect cancer early.

Recursion is a breakthrough drug discovery company that combines a novel computer vision platform with deep disease biology and chemistry.

Cancer remains one of the leading causes of death in the U.S. and worldwide.

Ophelia is reinventing addiction treatment and dramatically improving access to best-in-class care with telemedicine.

In the face of a national emergency in child and adolescent mental health, urgent measures are needed to help those in need.

Attention Digital Health Founders: We are now accepting applications to attend the Digital Health Founder’s Fellowship

Riva’s mission is to improve cardiovascular disease worldwide using just the smartphones that people already have in their pockets, replacing 130-year-old blood pressure cuff technology.

Across life sciences, a quality management system (QMS) is critical for both regulatory compliance and continuous product innovation.

Insurtech has been hot—at least seven venture-backed insurers will have gone public since the second half of 2020.

Opioid use disorder (OUD) is an epidemic that will define our generation. Roughly 90 million Americans use opioids and over 10 million misuse them.

The COVID-19 pandemic changed the world of benefits forever. Companies rethought the traditional office paradigm and re-evaluated the suite of benefits that provide a strong work experience for employees.

We believe purpose-built vertical SaaS will help make drug discovery more effective and efficient and ultimately improve healthcare outcomes.

At Menlo, we believe the pace of innovation in new medicines will continue to accelerate, powered by the combination of advances in biology, advances in information technology, and even the lasting implications of the global pandemic.